1. Products
  2. Solutions
  3. Insights+
  4. News & content
  5. About
  1. Launch
Book a demo
-
  1. My Preqin
  1. Products
  2. Solutions
  3. Insights+
  4. News & content
  5. About
  1. Launch
  1. My Preqin
Book a demo

Biocartis NV

Have updates for this profile?  Please contribute data

About Deals
= Subscriber Access Only

You are viewing a preview of this profile. Request a Preqin Pro demo for full access to all profiles and underlying data.

With Preqin Pro, you gain an unobstructed view of all alternative asset class activity across institutional investors, fund managers, funds, portfolio companies, deals, exits, and service providers.

Year established

2007

Location

Mechelen Belgium

Primary Industry

Biotechnology

About

Established in 2007 and based in Mechelen, Belgium, Biocartis NV is a biotechnology company that is focused on the delivery of versatile and compact molecular diagnostic platforms.
Current Investors
The Institute for the Promotion of Innovation by Science and Technology in Flanders, Wellcome Trust, Johnson & Johnson Innovation

Request a demo to show more

Primary Industry
Biotechnology
Sub Industries
Bioinformatics, Healthcare IT, Monitoring Equipment, Diagnostic Equipment
Website
www.biocartis.com
Verticals
HealthTech
Company Stage
Mature
Total Amount Raised
Subscriber access only

Deals

Deals Type
Recapitalisation
Deal Status Target (s) Deal Date Investor(s) Seller(s) Deal size (Mn) Enterprise value (Mn) Post-money valuation (Mn) EBITDA multiple (x) Revenue multiple (x) Lead partner (s)
Completed Biocartis NV 22 Nov 2023
Displaying 1-1 of 1

Time to go Pro

Get Preqin Pro for unrestricted access to 600,000+ detailed profiles on fund managers, investors, funds, companies, and other alternative asset players. Unlock exclusive data on future plans, company financials, fundraising history, track records, and more.
Sign in Request demo